Geltor Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
83

- Latest Deal Type
-
2ndary - Private
- Latest Deal Amount
-
$9.5M
- Investors
-
39
Geltor General Information
Description
Operator of a biodesign company intended to offer a selection of designer proteins with biocompatibility, functionality, and other benefits. The company's products are animal-free, sustainably cultivated, and clinically demonstrated for high performance, enabling businesses to make products sustainably and grow towards a plant-based future.
Contact Information
Website
www.geltor.com
Formerly Known As
Gelzen
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Materials
Primary Office
- 1933 Davis Street
- Suite 312
- San Leandro, CA 94577
- United States
Geltor Timeline
Geltor Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Secondary Transaction - Private | 21-Feb-2022 | $9.5M | 00000 | 00000 | Completed | Generating Revenue |
3. Later Stage VC (Series B) | 27-Jul-2020 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series A) | 02-Oct-2018 | $21.2M | $21.4M | 0000 | Completed | Generating Revenue |
1. Accelerator/Incubator | 04-Sep-2015 | $250K | $250K | Completed | Startup |
Geltor Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
SAFE 3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
SAFE 2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
SAFE 1 | 3,678,868 | $0.000100 | $0.05 | $0.61 | $0.61 | 1x | $0.61 | 7.52% |
Series A | 11,804,156 | $0.000100 | $0.1 | $1.24 | $1.24 | 1x | $1.24 | 24.11% |
Geltor Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biodesign company intended to offer a selection of designer proteins with biocompatibility, functionality,
Biotechnology
San Leandro, CA
83
As of 2022
00000
0000
0000-00-00
00000000000
00000
Geltor Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Motif FoodWorks | Venture Capital-Backed | Boston, MA | 00 | 00000 | 0000000000 0 | 00000 |
000000 000000 | Venture Capital-Backed | Nutley, NJ | 000 | 00000 | 00000000000 | 00000 |
00000 (0000 000000 | Venture Capital-Backed | South San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
0000 0000000 | Venture Capital-Backed | Emeryville, CA | 000 | 00000 | 00000000000 | 00000 |
0000000 000 | Venture Capital-Backed | Berkeley, CA | 000 | 00000 | 00000000000 | 00000 |
Geltor Patents
Geltor Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11174300-B2 | Animal-free dietary collagen | Active | 24-Jan-2020 | 000000000 | 00 |
US-20210277075-A1 | Animal-free dietary collagen | Granted | 24-Jan-2020 | 000000000 | |
US-20200325211-A1 | Recombinant elastin and production thereof | Granted | 12-Apr-2019 | 000000000 | |
CA-3136691-A1 | Recombinant elastin and production thereof | Pending | 12-Apr-2019 | 000000000 | |
AU-2020270920-A1 | Recombinant elastin and production thereof | Pending | 12-Apr-2019 | C07K14/78 |
Geltor Executive Team (8)
Geltor Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Arvind Gupta | IndieBio | Board Member | 000 0000 |
Costa Yiannoulis | CPT Capital | Board Member | 000 0000 |
Daniel Phillips | Self | Board Member | 000 0000 |
Douglas Cameron Ph.D | Self | Board Member & Board Observer | 000 0000 |
Gina Boswell | Self | Board Member | 000 0000 |
Geltor Signals
Geltor Investors (39)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Agronomics | Venture Capital | Minority | 000 0000 | 000000 0 | |
Alwyn Capital | Impact Investing | Minority | 000 0000 | 000000 0 | |
Blue Horizon Corporation | Impact Investing | Minority | 000 0000 | 000000 0 | |
Brian Frank | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Bruce Friedrich | Angel (individual) | Minority | 000 0000 | 000000 0 |